Literature DB >> 19757024

Study on DBH genetic polymorphisms and plasma activity in attention deficit hyperactivity disorder patients from Eastern India.

Nipa Bhaduri1, Kanyakumarika Sarkar, Swagata Sinha, Anindita Chattopadhyay, Kanchan Mukhopadhyay.   

Abstract

Dysfunctions in the norepinephric pathway have been speculated in the etiology of attention deficit hyperactivity disorder (ADHD), a common problem for children. Synthesis of norepinephrine from dopamine is catalyzed by the enzyme dopamine beta-hydroxylase and numerous polymorphisms in the DBH gene have been found to exert their direct influence on the enzyme activity independently. In the present study association of ADHD with four genetic polymorphisms, DBH-STR, rs1611115, rs1108580, and rs2519152, was examined in subjects belonging to eastern India. ADHD subjects (n = 111) were recruited following DSM-IV criteria. Peripheral blood samples were collected from nuclear families with ADHD probands. A group of ethnically matched healthy volunteers (n = 130) was also recruited. Genomic DNA was analyzed by PCR amplification followed by restriction digestion and genotyping. Data obtained were subjected to both family-based as well as population-based statistical analyses. Plasma DbetaH activity was measured using a photometric assay and its correlation with the genetic polymorphisms was analyzed using analysis of variance. Case-control analysis revealed no significant differences in allelic frequencies; however, significant paternal over-transmission (P = 0.02) of the rs2519152 'G' allele to ADHD probands was noticed. A haplotype, composed of 12R-C-G-G, also showed biased transmission. Strong correlation was observed between enzyme activity and rs1611115, rs1108580, and rs2519152 (P = 1.51E-6, 0.04, and 0.003, respectively). The present study hints toward the fact that DBH gene polymorphisms have some role in the etiology of ADHD in eastern Indian population and their study could be useful for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19757024     DOI: 10.1007/s10571-009-9448-5

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  37 in total

1.  Pedigree disequilibrium tests for multilocus haplotypes.

Authors:  Frank Dudbridge
Journal:  Genet Epidemiol       Date:  2003-09       Impact factor: 2.135

2.  Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits.

Authors:  S Purcell; S S Cherny; P C Sham
Journal:  Bioinformatics       Date:  2003-01       Impact factor: 6.937

3.  Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children.

Authors:  G Daly; Z Hawi; M Fitzgerald; M Gill
Journal:  Mol Psychiatry       Date:  1999-03       Impact factor: 15.992

Review 4.  Molecular genetics of attention-deficit/hyperactivity disorder.

Authors:  Stephen V Faraone; Roy H Perlis; Alysa E Doyle; Jordan W Smoller; Jennifer J Goralnick; Meredith A Holmgren; Pamela Sklar
Journal:  Biol Psychiatry       Date:  2005-01-21       Impact factor: 13.382

5.  Analysis of polymorphisms in the dopamine beta hydroxylase gene: association with attention deficit hyperactivity disorder in Indian children.

Authors:  Nipa Bhaduri; Swagata Sinha; Anindita Chattopadhyay; Prasanta Kumar Gangopadhyay; Manoranjan Singh; Kanchan Kumar Mukhopadhyay
Journal:  Indian Pediatr       Date:  2005-02       Impact factor: 1.411

6.  A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus.

Authors:  C P Zabetian; G M Anderson; S G Buxbaum; R C Elston; H Ichinose; T Nagatsu; K S Kim; C H Kim; R T Malison; J Gelernter; J F Cubells
Journal:  Am J Hum Genet       Date:  2001-01-19       Impact factor: 11.025

7.  Segregation and linkage studies of plasma dopamine-beta-hydroxylase (DBH), erythrocyte catechol-O-methyltransferase (COMT), and platelet monoamine oxidase (MAO): possible linkage between the ABO locus and a gene controlling DBH activity.

Authors:  L R Goldin; E S Gershon; C R Lake; D L Murphy; M McGinniss; R S Sparkes
Journal:  Am J Hum Genet       Date:  1982-03       Impact factor: 11.025

8.  The structure of linkage disequilibrium at the DBH locus strongly influences the magnitude of association between diallelic markers and plasma dopamine beta-hydroxylase activity.

Authors:  Cyrus P Zabetian; Sarah G Buxbaum; Robert C Elston; Michael D Köhnke; George M Anderson; Joel Gelernter; Joseph F Cubells
Journal:  Am J Hum Genet       Date:  2003-04-30       Impact factor: 11.025

9.  Human serum dopamine beta-hydroxylase: correlation of enzymatic activity with immunoreactive protein in genetically defined samples.

Authors:  J Dunnette; R Weinshilboum
Journal:  Am J Hum Genet       Date:  1976-03       Impact factor: 11.025

10.  Genotypic and haplotypic associations of the DBH gene with plasma dopamine beta-hydroxylase activity in African Americans.

Authors:  Yi-lang Tang; Michael P Epstein; George M Anderson; Cyrus P Zabetian; Joseph F Cubells
Journal:  Eur J Hum Genet       Date:  2007-04-25       Impact factor: 4.246

View more
  4 in total

1.  Association between polymorphisms of the DBH and DAT1 genes and attention deficit hyperactivity disorder in children from Jordan.

Authors:  Mohammad Y Gharaibeh; Sajida Batayneh; Omar F Khabour; Azhar Daoud
Journal:  Exp Ther Med       Date:  2010-07-01       Impact factor: 2.447

2.  Nicotine dependence as a moderator of genetic influences on smoking cessation treatment outcome.

Authors:  Adam M Leventhal; Wonho Lee; Andrew W Bergen; Gary E Swan; Rachel F Tyndale; Caryn Lerman; David V Conti
Journal:  Drug Alcohol Depend       Date:  2014-03-05       Impact factor: 4.492

Review 3.  Attention-deficit/hyperactive disorder updates.

Authors:  Miriam Kessi; Haolin Duan; Juan Xiong; Baiyu Chen; Fang He; Lifen Yang; Yanli Ma; Olumuyiwa A Bamgbade; Jing Peng; Fei Yin
Journal:  Front Mol Neurosci       Date:  2022-09-21       Impact factor: 6.261

4.  Generation of Two Noradrenergic-Specific Dopamine-Beta-Hydroxylase-FLPo Knock-In Mice Using CRISPR/Cas9-Mediated Targeting in Embryonic Stem Cells.

Authors:  Jenny J Sun; Russell Ray
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.